Categories: EHRNewsPatient Care

New EHR tool empowers dermatologists with comprehensive medication side effects insights

EZDERM’s “Side Effects Module” streamlines dermatology exams while increasing patient safety

NAPLES, Fla., July 9, 2024 /PRNewswire/ — EZDERM, a leading provider of dermatology software solutions, today announced the launch of its Side Effects Module. The new enhancement to its electronic health record (EHR) solution enables dermatologists to identify, comprehensive, categorized patient medication side effects directly  the dermatology assessment  workflow, significantly improving patient safety and clinical efficiency. This integration with Surescripts, the leading U.S. health information network for tracking prescribed medications, offers dermatologists a reliable and efficient way to identify and manage medication-induced dermatologic reactions, enhancing patient safety, streamlining documentation, and improving clinical decision-making. 

  • Enhanced Patient Safety: The Side Effects module will display a list of a patient’s medications dispensed by any U.S. pharmacy up to six months prior to their visit date, along with their adverse reactions, ensuring these reactions are accurately identified and promptly addressed.
  • Streamlined Documentation: Once identified, Side Effects automatically documents the relevant information in the patient progress notes, reducing manual entry for dermatologists and minimizing the risk of errors.
  • Improved Clinical Decision-Making: Side Effects provides dermatologists with an enhanced view of potential causes of a patient’s chief complaint, allowing for quicker and more accurate identification of the root cause of skin issues.

“EZDERM’s new Side Effects Module is a game-changer for dermatologists, especially with the rise of new chemotherapeutic and biologic therapies, which have an ever-growing list of side effects,” says Dr. Srdjan Prodanovich, MD, FAAD, chief medical officer at EZDERM and practicing dermatologist. “This module allows dermatologists to quickly check a comprehensive list of side effects, conveniently divided into dermatology-related and other side effects, to quickly identify the possible culprit medications for a patient’s symptoms, saving valuable time, minimizing unnecessary treatments, and improving patient care.”

The Side Effects Module has automatically been added to the software solution for all EZDERM users. For more information on the Side Effects Module, visit EZDERM’s product page.  

About EZDERM:
EZDERM is a leading provider of dermatology software solutions, dedicated to enhancing patient care and streamlining practice management. Their dermatology-specific EHR features a unique, anatomical 3D Body Map tool for precise documentation of patient visits. Known for delivering the best value and exceptional support, their comprehensive suite of tools, including a robust revenue cycle management service, empowers dermatologists to optimize their practice efficiently and effectively. With a focus on innovation and customer satisfaction, EZDERM continues to set the standard in dermatology software, ensuring that dermatologists have the resources they need to provide top-quality care and easily manage their practices.

For additional information, please contact:
Jeff Rusack
Media Relations Manager
KNB Communications
EZDerm@KNBcomm.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-ehr-tool-empowers-dermatologists-with-comprehensive-medication-side-effects-insights-302191428.html

SOURCE EZDERM

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago